MiTeGen Spring 2012 Catalog Available Online or in Hardcopy

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, has released a catalog of their current products for crystallographers. - June 15, 2012 - MiTeGen, LLC

MiTeGen Awarded $185K NIH Phase I STTR Grant to Develop Hyperquenching Devices

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a Phase I STTR (small business technology transfer program) award from the NIH (National Institute of Health) for the development of a rapid crystal cooling device (“hyperquencher”) for cryocrystallography. - June 15, 2012 - MiTeGen, LLC

Inventys Research Butibori (Nagpur) Plant, Achieves ISO 9001:2008, ISO 14000:2004, and ISO 18000:OSHAS Certification

Inventys Research Butibori (Nagpur) Plant, Achieves ISO 9001:2008, ISO 14000:2004, and ISO 18000:OSHAS Certification

Inventys Research Company has achieved ISO 9001:2008, 14001:2004 and 18000:OSHAS Management System accreditation. The ISO 9001:2008 certification of compliance recognizes that the policies, practices, and procedures of Inventys ensure consistent quality in the products and services Inventys... - June 13, 2012 - Inventys Research Company Pvt Ltd.

SFL’s Senior Communication Manager to Speak at the 8th Annual Conference of the Pharmaceutical Contract Management Group

SFL is pleased to announce that Dr Faiz Kermani, Senior Communication Manager, will be giving a presentation entitled “The Regulatory Framework for New Drug Innovation” at the 8th Annual Conference of the Pharmaceutical Contract Management Group. - June 09, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd

AnaSpec Offers Anti-5-Methylcytidine (Clone 33D3)

AnaSpec, EGT Group is pleased to offer Eurogentec’s popular monoclonal antibody, anti-5-methylcytidine (Clone 33D3) for use in epigenetics research. Purified from ascites, this IgG1 / λ isotype antibody is supplied as a 1 mg/ml solution (in PBS) and is available in three sizes (0.1 mg,... - June 06, 2012 - AnaSpec, EGT Group

OmegaH2O® Clear Shelf Stable Omega-3, CoQ10 and Other Non Polar Compounds Patent Application 12/383,244 Approved in Europe and Notice of Allowance in U.S.

OmegaH2O® Clear Shelf Stable Omega-3, CoQ10 and Other Non Polar Compounds Patent Application 12/383,244 Approved in Europe and Notice of Allowance in U.S.

VIRUN, Inc. Food and Beverage Technology Division announces today that without continuance and as a result of innovation and novelty; patent application 12/383,244 has been approved in Europe and Notice of Allowance in the U.S. 12/383,244 allows the only patented non polar compounds, such as Omega-3, dissolve into foods, beverages and supplements clearer and shelf stable. - June 04, 2012 - VIRUN

Royal Care Pharmacy (RCP) Joins PCCA

RCP is pleased to announce PCCA membership. - May 31, 2012 - Royal Care Pharmacy Inc

AnaSpec Offers a Wide Selection of GO® Histone Peptides

AnaSpec, EGT Group offers a wide selection of GO® (catalog) Histone peptides that are biotin-labeled. Single or combinations of post-translational modified (PTM) amino acid-containing biotinylated histone peptide sequences have been used in applications such as pull-down assays.1-2 Generally... - May 31, 2012 - AnaSpec, EGT Group

TransEnterix's Single-Incision SPIDER® Surgical System Used for First Time in UK

International renowned surgeon Dr. Michel Ganger performed gastric sleeve through patient's belly button. - May 31, 2012 - TransEnterix

AnaSpec Showcases Fluorescent Nucleic Acid Probes

The detection of nucleic acids is important for many life science research tasks, such as sequencing, cDNA synthesis and cloning, RNA transcription and transfection. Accurate detection of DNA/RNA is key to the success of these techniques. DNA/RNA concentration is often measured by UV absorbance at... - May 19, 2012 - AnaSpec, EGT Group

AnaSpec Offers PEGylated Peptides Synthesis

PEGylation has become a well-accepted method for the delivery of biopharmaceuticals-especially peptide and protein drugs.1-4 Simple modification of a drug with polyethylene glycol (PEG) not only is capable of improving the drug’s solubility, diminishing the potential for aggregation, and... - May 16, 2012 - AnaSpec, EGT Group

Grand Rounds at Metropolitan Hospital - Compounding Options in Medicine: Special Focus on Physiatry

Dr Haldey, PharmD, President of Royal Care Pharmacy, Inc, will provide a comprehensive overview of pharmacy compounding with a specific focus on physiatry. - May 12, 2012 - Royal Care Pharmacy Inc

Royal Care Pharmacy Will Present at the 5th Annual Wound Symposium

Dr Emil Haldey, the Company’s President, has been invited to speak at the 5th Annual Wound Care Symposium sponsored by NY College of Podiatric Medicine and Nassau University Medical Center. Dr Emil Haldey will discuss history, rationale and benefits of pharmacy compounding for the modern podiatry practice. - May 12, 2012 - Royal Care Pharmacy Inc

Mitegen Announces Consolidation and Improvements to MicroLoops™ Product Lines

MicroLoops™ and MicroLoops™ HT product lines merged and improved with Dual thickness technology, providing an economical option in premium crystal mounts. - May 09, 2012 - MiTeGen, LLC

AnaSpec Highlights SensoLyte® 520 Renin Assays for Human, Mouse & Rat Specific

AnaSpec, EGT Group, the provider of the ultra-sensitive SensoLyte® 520 Human Renin Assay Kit also provides renin kits specific for mouse and rat - the SensoLyte® 520 Mouse Renin Assay Kit and SensoLyte® 520 Rat Renin Assay Kit. Using proprietary 5-FAM/QXL™ 520 fluorescence... - May 09, 2012 - AnaSpec, EGT Group

OSO BioPharmaceuticals Invests $5 Million in Aseptic Filling Suite

State-of-the-art line will increase capacity and yield of liquid, suspension and lyophilized products. - May 02, 2012 - OSO BioPharmaceuticals Manufacturing, LLC

Carotech to Share Latest Breakthrough in Tocomin SupraBio Research at SupplySide MarketPlace, New York

They will be sharing with customers and visitors the latest clinical data of their patented and bioenhanced natural full spectrum palm tocotrienol complex. - April 27, 2012 - Carotech Inc.

AnaSpec Introduces Pancreatic β-Cells Specific Antibodies - Anti-hFXYD2γa

AnaSpec, EGT Group is pleased to announce the release of three antibodies (two monoclonal and one polyclonal) against FXYD2γa. FXYD2γa is a regulating subunit of the NA+-K+-ATPase and has been identified as a unique and specific pancreatic beta cell surface biomarker. In individuals... - April 19, 2012 - AnaSpec, EGT Group

RayBiotech, Inc. and Innopsys Announce Co-Marketing Partnership

RayBiotech, Inc. today announced that it has entered into a co-marketing partnership with Innopsys of Carbonne, France to promote the sales of RayBiotech’s G-Series and Quantibody series of antibody arrays and array testing services with Innopsys’ Innoscan laser microarray scanning... - April 13, 2012 - RayBiotech, Inc

U.S. Granted Patent 8,088,385 B2 Strengthens Advanced Cancer Therapeutics’ Anti-Cancer Product Portfolio

Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, today announced that it has been granted U.S. Patent 8,088,385 B2 titled “PFKFB3 inhibitor for the treatment of a Proliferative Cancer” by the United States Patent... - April 04, 2012 - Advanced Cancer Therapeutics

AnaSpec Highlights HiLyte Fluor™ Dyes Collection for Labeling Amine and Thiol-Modified Oligos

AnaSpec is pleased to highlight their wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines, and AnaSpec’s own proprietary HiLyte Fluor™ dyes for labeling amine and thiol modified oligonucleotides. Fluorescent dye-labeled oligos are widely used as... - March 29, 2012 - AnaSpec, EGT Group

Carotech to Showcase Natural Palm Mixed Carotene (Caromin) & Palm Tocotrienol Complex (Tocomin) at FIC 2012, Shanghai

Carotech will share latest scientific developments and application strategies of its Tocomin and Caromin series of ingredients - March 24, 2012 - Carotech Inc.

AnaSpec Develops AMC Resins for SPPS

Peptide-7-amino-4-methylcoumarin conjugates (peptide-AMCs) are widely used as fluorogenic substrates to study proteases. The preparation of peptide-AMCs usually involves solution phase synthesis since AMC lacks an additional functional group for attachment to a solid support. Although solid-phase... - March 22, 2012 - AnaSpec, EGT Group

MoBiTec GmbH, Germany, Closes Distribution Agreement for Transcreener® HTS System Platform with BellBrooks Labs, USA

BellBrook Labs, USA, is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies. Their proprietary Transcreener® HTS Platform was developed to move more new targets into HTS more rapidly, and to streamline selectivity profiling within a target family. The partnership with MoBiTec, Germany, will enable BBL to offer their excellent products for High-Throughput Screening to scientists in Germany. - March 14, 2012 - MoBiTec GmbH

RRI Group/Akesis Has Been Part of 60 Dermatology Development Programs

Let RRI Group/Akesis put its Clinical Experience to work for you. RRI Group/Akesis' passion is helping Companies...Grow. - March 08, 2012 - RRI Group/Akesis

TransEnterix to Unveil New SPIDER Surgical System Instruments at SAGES

Platform delivers smallest incision in single-site market while replicating triangulation of multi-port systems - March 02, 2012 - TransEnterix

MoBiTec GmbH, Germany, to Exhibit at Annual Conference of the Association for General and Applied Microbiology (VAAM) 2012 in Tuebingen, Germany

Presentation of new High End Imaging Tools and Accessories for Cell Culture and Light and Fluorescence Microscopy, Systems for Safe Collection and Transportation of Parasite Material, and a Comprehensive Compilation Booklet on Cell Viability and Cytotoxicity Assays at German Conference of the Association for General and Applied Microbiology (VAAM) 2012. - March 02, 2012 - MoBiTec GmbH

MoBiTec GmbH, Germany, Offers a New Photoconvertible and Photoactivatible Fluorescent Protein Suitable for High-Resolution Microscopy: mIrisFP

MoBiTec GmbH, Germany, supplier of fluorescent probes, screening kits and imaging ware for cutting-edge fluorescence applications and microscopy, introduces mIrisFP, a photoconvertible and photoactivatible fluorescent protein suitable for High-Resolution microscopy: mIrisFP - February 29, 2012 - MoBiTec GmbH

Mitegen Announces Continued Expansion of Product Lines and Offerings for Crystallographers

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, recently announced numerous expansions to both their patented product portfolio and to their line of distributed products. - February 25, 2012 - MiTeGen, LLC

MoBiTec GmbH, Germany, Launches Sale of High End Imaging Tools and Accessories for Cell Culture and Light and Fluorescence Microscopy

MoBiTec GmbH, Germany, Launches Sale of High End Imaging Tools and Accessories for Cell Culture and Light and Fluorescence Microscopy

MoBiTec GmbH, Germany, supplier of fluorescent probes and research chemicals, introduces a collection of high end imaging tools for cell based imaging, assays and arrays. The product line includes Imaging Dishes and adequate Stage Frames, Imaging Plates, Imaging Chambers, Slide Tray Plates and Affinity Adhesion Slides. For the design of the products excellent materials, high quality processing and assembly technologies and innovative construction principles were chosen. - February 24, 2012 - MoBiTec GmbH

Mitegen Announces Distribution Agreement with Mexico Diffractia S. de R.L.de C.V.

Mitegen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed a distribution agreement with Mexico Diffractia S. de R.L.de C.V. of... - February 24, 2012 - MiTeGen, LLC

AnaSpec Offers Symmetric & Asymmetric Dimethylated Arginine in Histone Peptides Collection

AnaSpec, EGT Group offers one of the world’s largest selections of Histone GO® (catalog) peptides. The peptides include sequences containing modified amino acids such as methylated (Me1, Me2 and Me3) Lysine; phosphorylated Threonine (pThr) or Serine (pSer); deiminated Arginine (Cit). - February 23, 2012 - AnaSpec, EGT Group

OsoBio Appoints Marian Meyer Director of Labs

Meyer manages the company’s chemistry and microbiology labs, which are responsible for such quality-control services as materials testing and release, environmental monitoring and analytical methods compliance. - February 23, 2012 - OSO BioPharmaceuticals Manufacturing, LLC

AnaSpec Offers Special Pricing for MOG (1-125) Recombinant Proteins

AnaSpec, EGT the first provider of commercial MOG recombinant proteins is pleased to offer a 50% discount off on MOG (1-125) recombinant proteins through the month of February, 2012 to US and Canadian customers. Please mention code “rMOG50%” when ordering to get the discount. AnaSpec's... - February 16, 2012 - AnaSpec, EGT Group

Milton Boyer Named President of OSO BioPharmaceuticals Manufacturing

Boyer has been responsible for guiding business strategies and creating new growth opportunities at OsoBio since 2008 - February 15, 2012 - OSO BioPharmaceuticals Manufacturing, LLC

AnaSpec Introduces SensoLyte® Factor Xa Activity Assays – Industry’s First Fluorimetric Kits

AnaSpec, EGT Group is pleased to announce the release of the industry first fluorimetric Factor Xa activity assays - The SensoLyte® 520 Factor Xa Assay Kit and the SensoLyte® Rh110 Factor Xa Assay Kit. The SensoLyte® 520 Factor Xa Assay Kit employs a FRET (5-FAM/QXL™ 520)... - February 15, 2012 - AnaSpec, EGT Group

SFL’s Managing Director to Speak at Healthcare Businesswomen’s Association Event

SFL is pleased to announce that Shayesteh Fürst-Ladani, Managing Director of the company, will be speaking at the upcoming Healthcare Businesswomen’s Association European meeting entitled “The Role of Regulatory Affairs in Successful Development and Launch of Healthcare Products” to be held in Basel, Switzerland. - February 09, 2012 - SFL Regulatory Affairs & Scientific Communication Ltd

AnaSpec Offers Antibodies Against the Hexa-His and GFP Tags

The introduction of tags, whether short peptides (6X-His, DYKDDDDK, c-myc) or proteins (green fluorescent protein – GFP, glutathione-s-transferase – GST) into recombinant proteins aids in the characterization, localization or purification of the recombinant expressed protein.1-3 As a... - February 03, 2012 - AnaSpec, EGT Group

AnaSpec Highlights Calcein AM for Live Cell Staining

Calcein AM (Calcein acetoxymethyl ester), a non-fluorescent, cell permeable compound, converts to the strongly green fluorescent calcein when hydrolyzed by intracellular esterases in live cells.1-2 It is widely used for determining cell viability since the fluorescence intensity of calcein is... - February 02, 2012 - AnaSpec, EGT Group

AnaSpec Highlights Atrial Natriuretic Peptides in GO® Collection

AnaSpec, EGT Group provides a wide range of GO® (catalog) natriuretic peptides for use in research laboratories. Their selection of atrial natriuretic peptides (ANPs) include the biologically active 1-28 amino acid peptide (human/porcine or rat sequences); shorter ANP fragments; and Biotin, FAM... - February 02, 2012 - AnaSpec, EGT Group

Advanced Cancer Therapeutics Chief Scientific Officer to Present Preclinical Data on Glycolysis Inhibitors at World Cancer Metabolism Summit

Advanced Cancer Therapeutics, LLC (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that Dr. Gilles Tapolsky, ACT’s Chief Scientific Officer, has been selected to present at the World Cancer Metabolism Summit to be held February 1 – February 2, 2012 in Washington, D.C. - February 01, 2012 - Advanced Cancer Therapeutics

Novus Biologicals Added as New Preferred Vendor for the University of Washington

Novus Biologicals is excited to be a preferred vendor for the University of Washington. Novus’ extensive product line will soon be added to the UW online ordering system, and all UW researchers will now receive 5% off any order. Novus Biologicals is committed to developing and maintaining... - January 28, 2012 - Novus Biologicals

AnaSpec Expands SensoLyte® 520 Renin Assay Kits Collection

AnaSpec, the provider of the ultra-sensitive SensoLyte® 520 Human Renin Assay Kit now provides renin kits specific for mouse and rat - the SensoLyte® 520 Mouse Renin Assay Kit and SensoLyte® 520 Rat Renin Assay Kit. Using their proprietary 5-FAM/QXL™ 520 fluorescence resonance... - January 25, 2012 - AnaSpec, EGT Group

AnaSpec Introduces SensoLyte® α-Synuclein ELISA Assay

AnaSpec, EGT Group is pleased to announce the release of an ultrasensitive ELISA assay for quantitatingα-synuclein. The SensoLyte® α-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) provides a convenient and quantitative assay for determining α-Synuclein amount in cell and... - January 25, 2012 - AnaSpec, EGT Group

AnaSpec Offers Speedy 28-Day Custom Polyclonal Antibody Service

When traditional protocols can take almost 90 days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec is pleased to introduce the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol... - January 25, 2012 - AnaSpec, EGT Group

AnaSpec Introduces Ultra-Sensitive SensoLyte® NADP/NADPH Assay Kit

AnaSpec, EGT Group, the provider of ultra-sensitive fluorimetric SensoLyte® line of assay kits is pleased to announce the release of the SensoLyte® Fluorimetric NADP/NADPH Assay Kit. This assay is a sensitive fluorimetric assay that detects NADP and NADPH without interfering with NAD/NADH. - January 19, 2012 - AnaSpec, EGT Group

AnaSpec Includes Ghrelin and Obestatin Peptides in GO® Collection

AnaSpec, EGT Group, a leading provider of integrated proteomic and genomic solutions, offers a wide range of ghrelin and obestatin GO® (catalog) peptides for research use. In 1999, Kojima and his group (1) reported the discovery of a growth hormone secretagogue that is involved in the release... - January 19, 2012 - AnaSpec, EGT Group

AnaSpec Highlights Its Proprietary HiLyte Fluor™ Dye Collection

AnaSpec, EGT Group’s proprietary HiLyte Fluor™ dyes are a series of excellent fluorescent labeling dyes with fluorescence emissions that span the full visible and near infrared spectrum. The hydrophilic property of most of the HiLyte Fluor™ dyes makes conjugations to protein... - January 17, 2012 - AnaSpec, EGT Group

CrystalGenomics Scores KRW 3 Billion in Strategic Equity Investment from KSLSF, a Life Science Fund Backed by the City of Seoul and the Ministry of Knowledge Economy

CrystalGenomics, Inc. (KOSDAQ: CRYSTAL [083790]), a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund (KSLSF). This is the third time within... - January 16, 2012 - CrystalGenomics, Inc.

John Quackenbush to Speak at CHI’s Bioinformatics & Cancerinformatics Conference, February 21-23, San Francisco, CA

Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session. - January 12, 2012 - Cambridge Healthtech Institute

Press Releases 801 - 850 of 1,343